|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00213421 |
|
Date of registration:
|
13/09/2005 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
August 2001 |
|
Target sample size:
|
330 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00213421 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Pascal Joly, MD-PHD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
UH Rouen |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- age > 18
- immunoflurescence, histological exam, predictive value according to bullous pemphigus
diagnostic
- consentment patient
Exclusion Criteria:
- age < 18
- no consentment
- localized bullous pemphigus (<400cm2)
- linear IgA pemphigus
- corticothérapy, immunotherapy
- pregnant woman pemphigus
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Bullous Pemphigoid
|
|
Intervention(s)
|
|
Drug: Dermoval
|
|
Secondary ID(s)
|
|
2000/014/HP
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|